Microphysiological Analysis Platform of Pancreatic Islet β‐Cell Spheroids. Issue 2 (28th December 2017)

• Record Type: Journal Article
• Authors: Lee, Sang Hun; Hong, SoonGweon; Song, Jihwan; Cho, Byungrae; Han, Esther J.; Kondapavulur, Sravani; Kim, Dongchoul; Lee, Luke P.
• Is Part Of: Advanced healthcare materials. Volume 7:Issue 2(2018)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2017-12-28
• Subjects: 3D cell culture -- diabetes -- organ‐on‐chip -- pancreatic islets -- regenerative medicine; Biomedical materials -- Periodicals; 610.28
• DOI: 10.1002/adhm.201701111
• Languages: English
• ISSNs: 2192-2640

Abstract

Abstract: The hallmarks of diabetics are insufficient secretion of insulin and dysregulation of glucagon. It is critical to understand release mechanisms of insulin, glucagon, and other hormones from the islets of Langerhans. In spite of remarkable advancements in diabetes research and practice, robust and reproducible models that can measure pancreatic β‐cell function are lacking. Here, a microphysiological analysis platform (MAP) that allows the uniform 3D spheroid formation of pancreatic β‐cell islets, large‐scale morphological phenotyping, and gene expression mapping of chronic glycemia and lipidemia development is reported. The MAP enables the scaffold‐free formation of densely packed β‐cell spheroids (i.e., multiple array of 110 bioreactors) surrounded with a perfusion flow network inspired by physiologically relevant microenvironment. The MAP permits dynamic perturbations on the β‐cell spheroids and the precise controls of glycemia and lipidemia, which allow us to confirm that cellular apoptosis in the β‐cell spheroid under hyperglycemia and hyperlipidemia is mostly dependent to a reactive oxygen species‐induced caspase‐mediated pathway. The β‐cells' MAP might provide a potential new map in the pathophysiological mechanisms of β cells. Abstract : There is a lack of suitable tools to produce 3D pancreatic islets in physiologically relevant microenvironments for the precise studies of human diabetes model. Microfluidic pancreatic islet model can provide a large‐scale temporal gene expression map that will enhance the fundamental pathophysiological understanding for diabetes and facilitate the translation of basic discoveries for effective therapeutic strategies.